Investec shaves 30bp off last deal with latest medical ABS
Investec Bank’s Australian operation priced a A$214.8m ($228.6m) asset-backed securitisation on Wednesday, closing a deal backed largely by loans to medical and accounting industry professionals. It followed a similar issue from Investec last year — but this time the lender managed to price the top tranche 30bp tighter.
The South African banks local subsidiary priced the A$196.1m A tranche at 135bp over the one-month bank-bill swap rate, in line with guidance and 30bp inside the top tranche of a A$240.7m deal it sold in May 2010.
"Were pretty happy with the pricing," said Barry Lanesman, head
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: firstname.lastname@example.org or find out more online here.